The US Commercial organization, part of the Global Hospital & Biosimilars organization, manages over 200 products across more than 10 therapeutic areas, generating over $2.5B in annual revenue. The US Commercial Biosimilars Portfolio, with approximately $1B in net revenue, includes eight BSM assets. The I&I Biosimilars Marketing Director is the P&L owner for the immunology portfolio, specifically Abrilada and Inflectra, which reach thousands of patients annually and generate over $400M in annual revenue within a highly dynamic and competitive marketplace. This role reports to the US Commercial Biosimilars Portfolio Lead and involves extensive collaboration with cross-functional partners including Global Hospital & Biosimilars, US Market Access, and Pfizer Global Supply. The position demands strong strategic, analytical, execution, interpersonal, and communication skills, along with agility to work with multiple stakeholders. The ideal candidate is a self-starter capable of managing multiple priorities, possesses attention to detail, and can lead and collaborate across the enterprise. Flexibility and urgency are crucial due to the fast-moving nature of the field. The Director is also responsible for developing strategies for personal and non-personal promotion targeting organized customers, HCPs, and patients.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Number of Employees
5,001-10,000 employees